COMMUNIQUÉS West-GlobeNewswire

IRIDEX Announces 2018 First Quarter Financial Results
03/05/2018
MOUNTAIN VIEW, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ) today reported financial results for the first quarter ended March 31, 2018. First Quarter Highlights Cyclo G6™ product revenue [...]
Allscripts announces first quarter 2018 results
03/05/2018
Reported first quarter growth of 24% in GAAP revenue to $514 million, 25% in non-GAAP revenue to $519 million; First quarter GAAP EPS of ($0.22) reflecting acquisition transaction fees, growth of 23% in non-GAAP EPS to [...]
Dermira Reports First Quarter 2018 Financial Results and Provides Corporate Update
03/05/2018
FDA decision on glycopyrronium tosylate New Drug Application expected by June 30, 2018 Lebrikizumab Phase 2b study enrolling patients, data expected in first half of 2019 MENLO PARK, Calif., May 03, 2018 (GLOBE NEWSWIRE [...]
Asterias Biotherapeutics to Report First Quarter 2018 Results on May 9, 2018
03/05/2018
FREMONT, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]
Diversicare Announces 2018 First Quarter Results
03/05/2018
BRENTWOOD, Tenn., May 03, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR ), a premier provider of long-term care services, today announced its results for the first quarter ended March 31, [...]
Invuity Announces First Quarter Financial Results
03/05/2018
SAN FRANCISCO, May 03, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announces financial results for the three months ended March [...]
Allscripts to significantly expand FollowMyHealth® patient engagement platform portfolio with new, advanced capabilities through acquisition of HealthGrid
03/05/2018
High-impact capabilities expected to enable providers to reach the entirety of their patient populations CHICAGO, May 03, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ), a global leader in healthcare technology, [...]
MyoKardia to Report First Quarter 2018 Financial Results on Tuesday, May 8, 2018
03/05/2018
SOUTH SAN FRANCISCO, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
G1 Therapeutics Provides First Quarter 2018 Corporate and Financial Update
03/05/2018
U.S. and European regulatory meetings scheduled based on positive trilaciclib Phase 2a myelopreservation data Preliminary data from G1T38 Phase 1b trial in breast cancer to be presented at ASCO on June 2 Management to [...]
Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
03/05/2018
LIVONIA, Mich., May 03, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]
Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results
03/05/2018
Company Pursuing U.S. Vitaros Partnership and Strategic Alternatives SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company seeking to advance innovative [...]
AveXis Reports First Quarter 2018 Financial and Operating Results
03/05/2018
-- Significant progress across operating functions including licensing, clinical trials and regulatory interactions -- -- AVXS-101 pre-BLA meeting with FDA is scheduled to be held in June 2018 -- CHICAGO, May 03, 2018 ( [...]
Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics for the Advancement of Multiple Gene Therapy Programs Aimed at Treating Distinct Forms of Limb-Girdle Muscular Dystrophies
03/05/2018
-- Sarepta strengthens position as a leader in gene therapy; expands rare disease franchise -- -- The program is designed, if successful, to offer first-ever corrective treatments for five distinct forms of Limb-girdle [...]
Sarepta Therapeutics Announces First Quarter 2018 Financial Results and Recent Corporate Developments
03/05/2018
-- First quarter 2017 EXONDYS 51 ® (eteplirsen) total net revenues of $64.6 million -- -- Sarepta signs exclusive partnership and buy-out option with Myonexus Therapeutics; pipeline expands from 16 to 21 programs -- -- [...]
Editas Medicine Announces First Quarter 2018 Results and Update
03/05/2018
Expanded Celgene collaboration to drive lead oncology program in solid tumors Strengthened Board of Directors with addition of James C. Mullen and Jessica Hopfield, Ph.D. Cash, cash equivalents, and marketable [...]
NewLink Genetics Reports First Quarter 2018 Financial Results
03/05/2018
Management to Host Conference Call Today at 4:30 p.m. ET AMES, Iowa, May 03, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported consolidated financial results for the first quarter 2018 [...]
CRISPR Therapeutics to Participate in May Investor Conferences
03/05/2018
ZUG, Switzerland and CAMBRIDGE, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
IntelGenx to Report First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow
03/05/2018
SAINT LAURENT, Quebec, May 03, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its first quarter 2018 financial results after market close on May [...]
Arbutus Announces Corporate Update and First Quarter 2018 Financial Results
03/05/2018
Two Novel HBV Candidates Planned to Enter Clinical Development in 2018 GalNAc Conjugated RNAi Agent Nominated to Enter IND-Enabling Studies Strategic Partnership with Roivant to Launch Genevant, an RNA Therapeutics [...]

Pages